AIRLINK 196.50 Increased By ▲ 2.94 (1.52%)
BOP 10.25 Increased By ▲ 0.30 (3.02%)
CNERGY 7.88 Decreased By ▼ -0.05 (-0.63%)
FCCL 39.80 Decreased By ▼ -0.85 (-2.09%)
FFL 17.09 Increased By ▲ 0.23 (1.36%)
FLYNG 27.12 Decreased By ▼ -0.63 (-2.27%)
HUBC 133.95 Increased By ▲ 1.37 (1.03%)
HUMNL 14.10 Increased By ▲ 0.21 (1.51%)
KEL 4.78 Increased By ▲ 0.18 (3.91%)
KOSM 6.64 Increased By ▲ 0.02 (0.3%)
MLCF 47.18 Decreased By ▼ -0.42 (-0.88%)
OGDC 214.79 Increased By ▲ 0.88 (0.41%)
PACE 6.96 Increased By ▲ 0.03 (0.43%)
PAEL 42.00 Increased By ▲ 0.76 (1.84%)
PIAHCLA 17.15 No Change ▼ 0.00 (0%)
PIBTL 8.50 Increased By ▲ 0.09 (1.07%)
POWER 9.60 Decreased By ▼ -0.04 (-0.41%)
PPL 183.96 Increased By ▲ 1.61 (0.88%)
PRL 42.90 Increased By ▲ 0.94 (2.24%)
PTC 25.15 Increased By ▲ 0.25 (1%)
SEARL 109.80 Increased By ▲ 2.96 (2.77%)
SILK 1.00 Increased By ▲ 0.01 (1.01%)
SSGC 44.11 Increased By ▲ 4.01 (10%)
SYM 17.86 Increased By ▲ 0.39 (2.23%)
TELE 8.96 Increased By ▲ 0.12 (1.36%)
TPLP 13.06 Increased By ▲ 0.31 (2.43%)
TRG 67.60 Increased By ▲ 0.65 (0.97%)
WAVESAPP 11.68 Increased By ▲ 0.35 (3.09%)
WTL 1.83 Increased By ▲ 0.04 (2.23%)
YOUW 3.97 Decreased By ▼ -0.10 (-2.46%)
BR100 12,249 Increased By 204.5 (1.7%)
BR30 36,933 Increased By 352.6 (0.96%)
KSE100 115,663 Increased By 1625.1 (1.43%)
KSE30 36,398 Increased By 603.9 (1.69%)

In a major breakthrough, scientists announced on November 20 they have generated stem cells from human skin which could help in the fight against major diseases and side-step the battle over using embryonic cells.
The discovery opens the door for promising research into using the blank-slate stem cells to test new drugs and study how diseases function without being forced to destroy embryos in the process, which has led to legal restrictions on research in the United States.
The researchers in Japan and the United States have also eliminated a major hurdle to using stem cells in treatments. The stem cells could eventually be generated with a specific patient's genetic code, eliminating the risk that the body would reject transplanted tissues or organs.
The new method is expected to rapidly advance research in the treatment of cancer, Alzheimer's and Parkinson's diseases, diabetes, arthritis, spinal cord injuries, strokes, burns and heart disease because scientists will have much greater access to stem cells.
"The work is monumental in its importance to the field of stem cell science and its potential impact on our ability to accelerate the benefits of this technology to the bedside," said Deepak Srivastava, director of the Gladstone Institute of Cardiovascular Disease.
"Not only does this discovery enable more research, it offers a new pathway to apply the benefits of stem cells to human disease."
Stem cells are seen as a possible magic bullet because they can be developed into any of the 220 types of cells in the human body. But research has been limited in the United States because of ethical concerns, and very few labs have had the resources and technical expertise to work with embryonic stem cells.
The new method is fairly straightforward and can be repeated by standard labs with relative ease, said study author James Thomson of the University of Wisconsin at Madison.
"My personal barometer of optimism has gone up a lot," Thomson said in a conference call. "Funding is finally going to go up because this does remove the political debate. And as we engage more and more people in the United States things are going to accelerate."
The White House hailed the discovery as a means of solving medical problems "without compromising either the high aims of science or the sanctity of human life." Two teams of researchers were simultaneously able to transform the skin cells by using a retrovirus to insert four different genes into the cells.
The Japanese team, led by Shinya Yamanaka of Kyoto University, managed to produce one stem cell line out of every 5,000 cells.

Copyright Agence France-Presse, 2007

Comments

Comments are closed.